These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 27297123)
21. Soybean lectin induces autophagy through P2RX7 dependent activation of NF-κB-ROS pathway to kill intracellular mycobacteria. Mishra A; Behura A; Kumar A; Ghosh A; Naik L; Mawatwal S; Mohanty SS; Mishra A; Saha S; Bhutia SK; Singh R; Dhiman R Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129806. PubMed ID: 33253803 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. Rienksma RA; Suarez-Diez M; Mollenkopf HJ; Dolganov GM; Dorhoi A; Schoolnik GK; Martins Dos Santos VA; Kaufmann SH; Schaap PJ; Gengenbacher M BMC Genomics; 2015 Feb; 16(1):34. PubMed ID: 25649146 [TBL] [Abstract][Full Text] [Related]
23. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
24. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Pey AL; Megarity CF; Timson DJ Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535 [TBL] [Abstract][Full Text] [Related]
25. Tuberculosis: Smart manipulation of a lethal host. Chaurasiya SK Microbiol Immunol; 2018 Jun; 62(6):361-379. PubMed ID: 29687912 [TBL] [Abstract][Full Text] [Related]
26. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2. Gu X; Gao Y; Mu DG; Fu EQ Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409 [TBL] [Abstract][Full Text] [Related]
27. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo. Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827 [TBL] [Abstract][Full Text] [Related]
28. Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification. Sarkar S; Leo BF; Carranza C; Chen S; Rivas-Santiago C; Porter AE; Ryan MP; Gow A; Chung KF; Tetley TD; Zhang JJ; Georgopoulos PG; Ohman-Strickland PA; Schwander S PLoS One; 2015; 10(11):e0143077. PubMed ID: 26580078 [TBL] [Abstract][Full Text] [Related]
29. Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC. Madajewski B; Boatman MA; Chakrabarti G; Boothman DA; Bey EA Mol Cancer Res; 2016 Jan; 14(1):14-25. PubMed ID: 26553038 [TBL] [Abstract][Full Text] [Related]
30. Ursolic Acid Activates Intracellular Killing Effect of Macrophages During Mycobacterium tuberculosis Infection. Podder B; Jang WS; Nam KW; Lee BE; Song HY J Microbiol Biotechnol; 2015 May; 25(5):738-44. PubMed ID: 25406534 [TBL] [Abstract][Full Text] [Related]
31. Mycobacterium tuberculosis PPE25 and PPE26 proteins expressed in Mycobacterium smegmatis modulate cytokine secretion in mouse macrophages and enhance mycobacterial survival. Mi Y; Bao L; Gu D; Luo T; Sun C; Yang G Res Microbiol; 2017 Apr; 168(3):234-243. PubMed ID: 27351106 [TBL] [Abstract][Full Text] [Related]
32. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism. Timson DJ Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity. Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233 [TBL] [Abstract][Full Text] [Related]
34. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones. Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of P2RX7 as a host-directed strategy for control of mycobacterial infection. Matty MA; Knudsen DR; Walton EM; Beerman RW; Cronan MR; Pyle CJ; Hernandez RE; Tobin DM Elife; 2019 Jan; 8():. PubMed ID: 30693866 [No Abstract] [Full Text] [Related]
36. Sirtuin 7 Regulates Nitric Oxide Production and Apoptosis to Promote Mycobacterial Clearance in Macrophages. Zhang S; Liu Y; Zhou X; Ou M; Xiao G; Li F; Wang Z; Wang Z; Liu L; Zhang G Front Immunol; 2021; 12():779235. PubMed ID: 34925356 [TBL] [Abstract][Full Text] [Related]
37. Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity. Nolan KA; Zhao H; Faulder PF; Frenkel AD; Timson DJ; Siegel D; Ross D; Burke TR; Stratford IJ; Bryce RA J Med Chem; 2007 Dec; 50(25):6316-25. PubMed ID: 17999461 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells. Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803 [TBL] [Abstract][Full Text] [Related]
39. Mycobacterium tuberculosis PPE44 (Rv2770c) is involved in response to multiple stresses and promotes the macrophage expression of IL-12 p40 and IL-6 via the p38, ERK, and NF-κB signaling axis. Yu Z; Zhang C; Zhou M; Li Q; Li H; Duan W; Li X; Feng Y; Xie J Int Immunopharmacol; 2017 Sep; 50():319-329. PubMed ID: 28743081 [TBL] [Abstract][Full Text] [Related]
40. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]